Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 27 results.
User Information
Export Records
  1. 1.   Unexpected tobacco etch virus (TEV) protease cleavage of recombinant human proteins
  2. Beaumont,Lauren; Mehalko,Jennifer; Johnson,Adam; Wall,Vanessa; Esposito,Dom
  3. Protein Expression and Purification. 2024, Apr 26; 220: 106488.
  1. 2.   Increased Protein Insolubility in Brains From a Subset of Patients With Schizophrenia
  2. Nucifora, Leslie G; MacDonald, Matthew L; Lee, Brian J; Peters, Matthew E; Norris, Alexis L; Orsburn, Benjamin C; Yang, Kun; Gleason, Kelly; Margolis, Russell L; Pevsner, Jonathan; Tamminga, Carol A; Sweet, Robert A; Ross, Christopher A; Sawa, Akira; Nucifora, Frederick C
  3. The American journal of psychiatry. 2019, SEP; 176(9): 730-743.
  1. 3.   Increased Protein Insolubility in Brains From a Subset of Patients With Schizophrenia
  2. Nucifora, Leslie; MacDonald, Matthew; Lee, Brian; Peters, Matthew; Norris, Alexis; Orsburn, Benjamin; Yang, Kun; Gleason, Kelly; Margolis, Russell; Pevsner, Jonathan; Tamminga, Carol; Sweet, Robert; Ross, Christopher; Sawa, Akira; Nucifora, Frederick
  3. BIOLOGICAL PSYCHIATRY. 2019, MAY 15; 85(10): S278-S278.
  1. 4.   Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents
  2. Devkota, L.; Lin, C. M.; Strecker, T. E.; Wang, Y.; Tidmore, J. K.; Chen, Z.; Guddneppanavar, R.; Jelinek, C. J.; Lopez, R.; Liu, L.; Hamel, E.; Mason, R. P.; Chaplin, D. J.; Trawick, M. L.; Pinney, K. G.
  3. Bioorganic & Medicinal Chemistry. 2016, 1-Mar; 24(5): 938-56.
  1. 5.   Ionic Liquids: Neoteric Solvents for Nucleoside Chemistry
  2. Kumar, V.; Parmar, V. S.; Malhotra, S. V.
  3. Current Organic Synthesis. 2011, Dec; 8(6): 777-786.
  1. 6.   Thermostable tag (TST) protein expression system: Engineering thermotolerant recombinant proteins and vaccines
  2. Luke, J. M.; Carnes, A. E.; Sun, P.; Hodgson, C. P.; Waugh, D. S.; Williams, J. A.
  3. Journal of Biotechnology. 2011, Feb; 151(3): 242-250.
  1. 7.   Structural modifications of nucleosides in ionic liquids
  2. Kumar, V.; Parmar, V. S.; Malhotra, S. V.
  3. Biochimie. 2010, Sep; 92(9): 1260-1265.
  1. 8.   Galectin-1 as a fusion partner for the production of soluble and folded human beta-1,4-galactosyltransferase-T7 in E. coil
  2. Pasek, M.; Boeggeman, E.; Ramakrishnan, B.; Qasba, P. K.
  3. Biochemical and Biophysical Research Communications. 2010, Apr; 394(3): 679-684.
  1. 9.   Soft alkyl ether prodrugs of a model phenolic drug: the effect of incorporation of ethyleneoxy groups on transdermal delivery
  2. Thomas, J. D.; Majumdar, S.; Sloan, K. B.
  3. Molecules (Basel, Switzerland). 2009 14(10): 4231-45.
  1. 10.   Overcoming Problems of Compound Storage in DMSO: Solvent and Process Alternatives
  2. Waybright, T. J.; Britt, J. R.; McCloud, T. G.
  3. Journal of Biomolecular Screening. 2009 14(6): 708-715.
  1. 12.   NMDA di-heteromeric receptor populations and associated proteins in rat hippocampus
  2. Al-Hallaq, R. A.; Conrads, T. P.; Veenstra, T. D.; Wenthold, R. J.
  3. Journal of Neuroscience. 2007, Aug; 27(31): 8334-8343.
  1. 13.   Conformationally constrained analogues of diacylglycerol (DAG). 27. Modulation of membrane translocation of protein kinase C (PKC) isozymes alpha and delta by diacylglycerol lactones (DAG-lactones) containing rigid-rod acyl groups
  2. Malolanarasimhan, K.; Kedei, N.; Sigano, D. M.; Kelley, J. A.; Lai, C. C.; Lewin, N. E.; Surawski, R. J.; Pavlyukovets, V. A.; Garfield, S. H.; Wincovitch, S.; Blumberg, P. M.; Marquez, V. E.
  3. Journal of Medicinal Chemistry. 2007, Mar; 50(5): 962-978.
  1. 14.   Enhanced soluble protein expression using two new fusion tags
  2. Chatterjee, D. K.; Esposito, D.
  3. Protein Expression and Purification. 2006, MAR; 46(1): 122-129.
  1. 15.   PABA/NO as an anticancer lead: Analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activity
  2. Saavedra, J. E.; Srinivasan, A.; Buzard, G. S.; Davies, K. M.; Waterhouse, D. J.; Inami, K.; Wilde, T. C.; Citro, M. L.; Cuellar, M.; Deschamps, J. R.; Parrish, D.; Shami, P. J.; Findlay, V. J.; Townsend, D. M.; Tew, K. D.; Singh, S.; Jia, L.; Ji, X. H.; Keefer, L. K.
  3. Journal of Medicinal Chemistry. 2006, FEB 9; 49(3): 1157-1164.
  1. 16.   Solubility-enhancing proteins MBP and NusA play a passive role in the folding of their fusion partners
  2. Nallamsetty, S.; Waugh, D. S.
  3. Protein Expression and Purification. 2006, JAN; 45(1): 175-182.
  1. 17.   Gateway vectors for the production of combinatorially-tagged His(6)-MBP fusion proteins in the cytoplasm and periplasm of Escherichia Coli
  2. Nallamsetty, S.; Austin, B. P.; Penrose, K. J.; Waugh, D. S.
  3. Protein Science. 2005, DEC; 14(12): 2964-2971.
  1. 18.   Making the most of affinity tags
  2. Waugh, D. S.
  3. Trends in Biotechnology. 2005, JUN; 23(6): 316-320.
  1. 19.   A pivotal role for reductive methylation in the de novo crystallization of a ternary complex composed of Yersinia pestis virulence factors YopN, SycN and YSc
  2. Schubot, F. D.; Waugh, D. S.
  3. Acta Crystallographica Section D-Biological Crystallography. 2004, NOV; 60(Part 11): 1981-1986.
  1. 21.   Characterization and quantitation of membrane proteomes using multidimensional MS-based proteomic technologies
  2. Blonder, J.; Conrads, T. P.; Veenstra, T. D.
  3. Expert Review of Proteomics. 2004, AUG; 1(2): 153-163.
  1. 22.   Maltodextrin-binding proteins from diverse bacteria and archaea are potent solubility enhancers
  2. Fox, J. D.; Routzahn, K. M.; Bucher, M. H.; Waugh, D. S.
  3. Febs Letters. 2003 537(1-3): 53-57.
  1. 23.   The N-terminal stem region of bovine and human beta 1,4- galactosyltransferase I increases the in vitro folding efficiency of their catalytic domain from inclusion bodies
  2. Boeggeman, E. E.; Ramakrishnan, B.; Qasba, P. K.
  3. Protein Expression and Purification. 2003 30(2): 219-229.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel